These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
343 related items for PubMed ID: 30170645
1. Tenecteplase versus streptokinase thrombolytic therapy in patients with mitral prosthetic valve thrombosis. Kathirvel D, Justin Paul G, Prathap Kumar G, Palanisamy G, Gnanavelu G, Ravishankar G, Swaminathan N, Venkatesan S. Indian Heart J; 2018; 70(4):506-510. PubMed ID: 30170645 [Abstract] [Full Text] [Related]
2. Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase. Kiran GR, Chandrasekhar P, Mohammad Ali S. Indian Heart J; 2021; 73(3):365-368. PubMed ID: 34154758 [Abstract] [Full Text] [Related]
3. Treatment of Prosthetic Valve Thrombosis with Bolus Dose Tenecteplase: An Experience from a Developing Country. Kumar Jha R, Bansal S, S Issar H, Chaudhary M, Sharma S. J Heart Valve Dis; 2017 May; 26(3):349-354. PubMed ID: 29092122 [Abstract] [Full Text] [Related]
4. Successful use of Tenecteplase in a patient with recurrence of prosthetic mitral valve thrombosis. Lahoti HA, Goyal BK. Indian Heart J; 2015 Dec; 67 Suppl 2(Suppl 2):S55-7. PubMed ID: 26688154 [Abstract] [Full Text] [Related]
5. Obstructive Thrombosis of Left-Sided Mechanical Heart Valves: Clinical Profile and Thrombolytic Therapy. Chandrakasu A, Jayachandran A, Gopinath Nayar P, Meyyappan C, Narayan G, Basha Abdul Bari A, Johnson Samuel P. J Heart Valve Dis; 2017 May; 26(3):344-348. PubMed ID: 29092121 [Abstract] [Full Text] [Related]
6. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. Özkan M, Gündüz S, Biteker M, Astarcioglu MA, Çevik C, Kaynak E, Yıldız M, Oğuz E, Aykan AÇ, Ertürk E, Karavelioğlu Y, Gökdeniz T, Kaya H, Gürsoy OM, Çakal B, Karakoyun S, Duran N, Özdemir N. JACC Cardiovasc Imaging; 2013 Feb; 6(2):206-16. PubMed ID: 23489534 [Abstract] [Full Text] [Related]
7. Thrombolysis for Left-Sided Prosthetic Valve Thrombosis: Short- and Long-Term Outcomes. Gupta S. J Heart Valve Dis; 2016 Mar; 25(2):214-220. PubMed ID: 27989070 [Abstract] [Full Text] [Related]
8. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase. Sakr SA, Abdel-Shakour H, Ramadan MM. Acta Clin Belg; 2015 Jun; 70(3):159-66. PubMed ID: 25495280 [Abstract] [Full Text] [Related]
9. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial. Özkan M, Gündüz S, Gürsoy OM, Karakoyun S, Astarcıoğlu MA, Kalçık M, Aykan AÇ, Çakal B, Bayram Z, Oğuz AE, Ertürk E, Yesin M, Gökdeniz T, Duran NE, Yıldız M, Esen AM. Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240 [Abstract] [Full Text] [Related]
10. Improvement of endothelial function early after thrombolytic therapy in patients with prosthetic heart valve thrombosis. Çakal B, Kalçık M, Güner A, Yesin M, Gürsoy MO, Gündüz S, Karakoyun S, Bayam E, Kalkan S, Özkan M. Turk Kardiyol Dern Ars; 2020 Sep; 48(6):566-575. PubMed ID: 32955025 [Abstract] [Full Text] [Related]
11. Intravenous thrombolytic treatment of mechanical prosthetic valve thrombosis: a study using serial transesophageal echocardiography. Ozkan M, Kaymaz C, Kirma C, Sönmez K, Ozdemir N, Balkanay M, Yakut C, Deligönül U. J Am Coll Cardiol; 2000 Jun; 35(7):1881-9. PubMed ID: 10841239 [Abstract] [Full Text] [Related]
12. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. Lengyel M, Vegh G, Vandor L. J Heart Valve Dis; 1999 Mar; 8(2):167-73. PubMed ID: 10224577 [Abstract] [Full Text] [Related]
13. Use of tenecteplase in recurrent prosthetic valve thrombosis. Hariram V, Sharma NP. J Heart Valve Dis; 2013 Nov; 22(6):872-3. PubMed ID: 24597413 [Abstract] [Full Text] [Related]
14. Successful thrombolysis of a subacute prosthetic valve thrombosis with modified ultra-slow thrombolytic therapy. Altay H, Kocabaş U, Yıldırımtürk Ö, Özkalaycı F, Sarıtaş B, Pehlivanoğlu S. Echocardiography; 2018 Aug; 35(8):1243-1244. PubMed ID: 29943853 [Abstract] [Full Text] [Related]
15. Short-course thrombolysis as the first line of therapy for cardiac valve thrombosis. Manteiga R, Carlos Souto J, Altès A, Mateo J, Arís A, Dominguez JM, Borrás X, Carreras F, Fontcuberta J. J Thorac Cardiovasc Surg; 1998 Apr; 115(4):780-4. PubMed ID: 9576210 [Abstract] [Full Text] [Related]
16. Thrombolytic therapy for prosthetic valve thrombosis: short- and long-term results. Gupta D, Kothari SS, Bahl VK, Goswami KC, Talwar KK, Manchanda SC, Venugopal P. Am Heart J; 2000 Dec; 140(6):906-16. PubMed ID: 11099995 [Abstract] [Full Text] [Related]
17. Predictors of the outcome of thrombolytic therapy in prosthetic mitral valve thrombosis: a study of 62 events. Nagy A, Dénes M, Lengyel M. J Heart Valve Dis; 2009 May; 18(3):268-75. PubMed ID: 19557981 [Abstract] [Full Text] [Related]
18. A Case Series of Obstructive Prosthetic Mitral Valve Thrombosis, Successfully Treated with Low-Dose, Slow Infusion Tissue-Type Plasminogen Activator. Ari H, Dogan A, Ceviker K, Aksoy F, Arslan A, Varol E. J Heart Valve Dis; 2015 May; 24(3):353-9. PubMed ID: 26901912 [Abstract] [Full Text] [Related]
19. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M. J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322 [Abstract] [Full Text] [Related]